Saturday 17 October 2026
Export VRXA’s income statement to Excel — free account
Veraxa Biotech AG
VRXA Healthcare Biotechnology
Insiders bought in the last twelve months.
1.11
0.01
+0.91%
Follow VRXA
Veraxa Biotech AG (VRXA) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CMPX Compass Therapeutics, Inc. compare | n/m |
| ADAG Adagene Inc. Sponsored ADR compare | n/m |
| WHWK Whitehawk Therapeutics, Inc. compare | n/m |
| MDWD MediWound Ltd. compare | n/m |
| CHRS Coherus Oncology, Inc. compare | n/m |
| IPHA Innate Pharma S.A. Sponsored ADR compare | n/m |
| DTIL Precision BioSciences, Inc. compare | n/m |
| ORMP Oramed Pharmaceuticals Inc. compare | 1.0× |
| VRXA Veraxa Biotech AG | — |
| Biotechnology industry median | 8.5× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)